Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still …

M Lucioni, C Rossi, P Lomoro, F Ballati, M Fanizza… - European …, 2021 - Springer
Purpose Breast lesions classified as of “uncertain malignant potential” represent a
heterogeneous group of abnormalities with an increased risk of associated malignancy …

Management of B3 lesions—practical issues

AM Shaaban, N Sharma - Current Breast cancer reports, 2019 - Springer
Abstract Purpose of the Review Breast lesions of uncertain malignant potential (B3) are a
heterogeneous group of diagnostic entities that can be associated with atypia. These are …

Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy

E Giannotti, JJ James, Y Chen, R Sun, A Karuppiah… - European …, 2021 - Springer
Objectives Traditionally B3 breast lesions are treated surgically, but overtreatment is a
concern, as the majority have a final benign diagnosis. A national screening program …

The upgrade risk of B3 lesions to (Pre) Invasive breast cancer after diagnosis on core needle or vacuum assisted biopsy. A Belgian national cohort study

N Willers, P Neven, G Floris, C Colpaert… - Clinical breast …, 2023 - Elsevier
Introduction Flat epithelial atypia (FEA), lobular neoplasia (LN), papillary lesions (PL), radial
scar (RS) and atypical ductal hyperplasia (ADH) are lesions of uncertain malignant potential …

The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England

N Sharma, E Cornford, S Cheung, H Price, O Kearins - Clinical Radiology, 2021 - Elsevier
AIM To assess the impact of vacuum-assisted excision (VAE) on the management of B3
lesions in the England NHS Breast Screening Programme following an update of national …

[HTML][HTML] Malignancy rate and malignancy risk assessment in different lesions of uncertain malignant potential in the breast (B3 lesions): an analysis of 192 cases from …

S Mohrmann, A Maier-Bode, F Dietzel, P Reinecke… - Breast Care, 2022 - karger.com
Background: The question of how to deal with B3 lesions is of emerging interest. Methods: In
the breast diagnostics of 192 patients between 2009 and 2016, a minimally invasive biopsy …

B3 lesion upgrade rates in a tertiary Australian breast centre: a 8‐year experience (2012–2019)

YY Huang, H Park, S McLaren… - ANZ journal of …, 2020 - Wiley Online Library
Background B3 breast lesions identified on core needle biopsy have uncertain malignant
potential. Traditional management of these lesions has been surgical excision, but there is …

[HTML][HTML] Rates and outcomes of breast lesions of uncertain malignant potential (B3) benchmarked against the National Breast Screening Pathology Audit; improving …

S El Sheikh, M Rathbone, K Chaudhary, A Joshi… - Clinical Breast …, 2022 - Elsevier
Introduction–Our breast screening unit was identified as high outlier for B3 lesions with a low
positive predictive value (PPV) compared to the England average. This prompted a detailed …

Ultrasound-guided 8-Gauge vacuum-assisted excision for selected B3 breast lesions: A preliminary experience

G Panzironi, G Moffa, F Galati, F Pediconi - La radiologia medica, 2022 - Springer
Purpose Nowadays, surgical excision is no longer justified for all B3 lesions and a minimally-
invasive therapeutic treatment has been encouraged. The aim of this study was to evaluate …

Percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions): a preliminary single-centre Italian experience

G Bicchierai, F Pugliese, F Amato, D De Benedetto… - La radiologia …, 2023 - Springer
Purpose In recent years vacuum-assisted excision (VAE) has been described as an
alternative treatment for some B3 lesions. This study aims to assess the effectiveness of …